Category Archives: Pr Newswire

Novel arenaviral therapeutic vaccine, developed in collaboration with Gilead Sciences, Inc. (Gilead), to be evaluated as a potential component of a curative regimen for human immunodeficiency virus (HIV) HOOKIPA achieves a $5 million non-dilutive milestone payment under its collaboration and license agreement with Gilead Under the collaboration agreement, HOOKIPA is responsible for advancing the HIV program […]

CHICAGO and SINGAPORE, July 2, 2024 /PRNewswire/ — Trading Technologies International, Inc. (TT), a global capital markets technology platform provider, announced today that it is now offering its clients access to Abaxx Exchange, a global commodity futures exchange and clearinghouse based in Singapore. The market launched on June 28, with the first trade executed through […]

OAK BROOK, Ill., July 2, 2024 /PRNewswire/ — Lions International celebrated several milestones during the 106th Lions International Convention in Melbourne, Australia. Nearly 10,000 Lions attended this pinnacle event to reconnect with Lions from around the world, discover innovative ways to grow and support clubs and commemorate another year of serving communities in need. From […]

PERTH, Australia, July 2, 2024 /PRNewswire/ — Bridgewest Perth Pharma, global pharmaceutical holding company with NovaCina CDMO division and LumaCina pharmaceutical supply division, announces the addition of renown Australian executive John Van Der Wielen to Board of Directors. Van Der Wielen will focus on Australian expansion programs for all three entities. Renown Australian executive John Van Der Wielen […]

JERSEY CITY, N.J. and SYDNEY, July 2, 2024 /PRNewswire/ — Global investment and trading technology solutions provider ViewTrade Holding Corporation has launched in Australia in a bid to deliver enhanced global market access, reduce inefficiencies caused by legacy infrastructure, and create investment avenues for the $9 trillion of superannuation assets expected to amass by 2041. […]

NEW YORK, July 2, 2024 /PRNewswire/ — Fly-E Group, Inc. (Nasdaq: FLYE) (“Fly-E” or the “Company”), an electric vehicle company engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters, and related accessories, today announced its financial results for the fiscal year ended March 31, 2024. Mr. Zhou (Andy) Ou, Chairman and […]

The first and only TMS company to establish comprehensive standards for patient care and responsiveness in the mental health industry MALVERN, Pa., July 01, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth […]

RESEARCH TRIANGLE PARK, N.C., July 01, 2024 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the Company has been added to the broad-market Russell 3000® and small-cap Russell 2000® Indexes as of the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets today, Monday, […]

DALLAS, July 01, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its inclusion in the Russell Microcap Index following the annual Russell Reconstitution, which took effect after the […]

Results demonstrate efficacy on bacterial growth in participants injected with RECCE® 327 (R327) at the highest tested dose of 4,000mg No serious adverse events and clinically significant changes observed, reinforcing safety profile of R327 The study determined an optimal dosing regimen for R327 intravenously, showing rapid onset and sustained impact on Escherichia coli via an […]